News >Bizchina

    Incubating a biotech future for tomorrow

    2011-08-19 16:19

    ?

    Incubating a biotech future for tomorrow
    From left, Pan Hao, Duan Peng and Ye Xin plan to set up a biotech venture in Nantong, Jiangsu province.[Photo/China Daily]

    Investment-friendly policies help pharma entrepreneurship blossom in Nantong

    Located close to the pharmaceutical hub of China lies the coastal city of Nantong in Jiangsu province that is fast emerging as a destination of choice for top-notch pharma professionals and companies.

    Backed by a slew of industry-friendly policies geared to attract investment, Nantong also has other advantages like its close proximity to the China Medicine Valley in Taizhou in Jiangsu and the Zhangjiang High-tech biotechnology zones in Shanghai, apart from convenient land and sea linkages.

    More than the geographical advantages, what has really underlined the city's advantage has been its ability to attract and retain overseas talent, especially expatriate Chinese pharma and biotech professionals.

    Duan Peng, a 35-year-old Chinese expatriate in the US, along with his four friends, are setting up a biotech venture in Nantong, Jiangsu province.

    Duan's startup is in the process of getting an initial funding from the local government at different levels, ranging from 100,000 yuan (10,878 euros) to 10 million yuan.

    What makes Duan and his team different from others is that they are all successful pharma professionals working in Fortune 500 companies or teaching in US universities who between them have over 10 years of expertise in modern biotechnology and drug development.

    Currently working as a research assistant professor in Rutgers, the State University of New Jersey, Duan has published several research papers in renowned journals and participated in several professional conferences apart from being a review committee member in several renowned trade journals like the European Journal of Pharmacology and European Journal of Pharmaceutical Science.

    "Although we are comfortable in America, we often felt that something was missing," says Ye Xin, Duan's partner in the venture.

    "The missing piece is a sense of achievement. Though we were well paid at the American companies, we wanted to be more than just employees. We are in our mid-30s and wanted to return home and make things happen."

    "Despite the rapid development of China's economy, it is still far behind developed countries in terms of biotechnology and drug development," Duan says. "We all have a dream. That is to devote what we have learned and our talent to the advancement of China's biotechnology and drug development. We hope to build a state-of-the-art biotech platform and products with our own property patent in Nantong, our hometown.

    "There are many advantages in setting up a biotech startup in Nantong," says Duan adding that the rapid pace at which the city developed has amazed him. "When I came back, I could hardly recognize that this is my hometown."

    Most of Nantong's gross domestic product (GDP) used to come from energy-intensive industries like textiles, construction and petrochemicals. But in recent years the city has embarked on a green trail and spurred promotion of high value-added and low-carbon industries like software and biotech.

    Li Zhaoyu, an executive with the Human Resources Department of the Nantong local government, says young professionals like Duan have been pioneering many of the new biotech ventures in the city.

    "Generous policies and tax returns for startup entrepreneurs, especially for the high-tech and high added value ones, are an attraction that many professionals find hard to resist," Duan says.

    But the real challenge for many professionals like Duan is to identify the sector they need to specialize in. Duan and his team decided to focus on detection kits that can diagnose colon cancer, brain tumor and other blood diseases in the early stages.

    Duan hopes his kits will end the monopoly of foreign testing kits in China and gain international acceptance as they will have their own patent. "With our diversity of expertise in biotech and pharmaceutical industry, we can cover all the stages of drug development. We are confident of the success of our products and the ability to realize our dreams," Duan says.

    Related News:

    亚洲人成人无码网www电影首页| 潮喷失禁大喷水aⅴ无码| 免费A级毛片无码A∨| 中文字幕日本高清| 毛片无码全部免费| 无码久久精品国产亚洲Av影片| 色综合久久精品中文字幕首页| 国产成人亚洲综合无码| 亚洲av永久无码精品网站 | 亚洲国产精品无码久久久秋霞2 | 中文字幕在线视频网| 无码少妇一区二区浪潮av| 日韩人妻精品无码一区二区三区| 日本在线中文字幕第一视频| 亚洲最大激情中文字幕| 久久久久亚洲?V成人无码| 免费无码VA一区二区三区| 中文字幕精品一区二区三区视频| 久久最近最新中文字幕大全| 亚洲精品无码久久不卡| 国产高清无码视频| heyzo专区无码综合| 无码精品一区二区三区在线| 亚洲欧洲无码AV电影在线观看| 中文字幕无码播放免费| 无码专区久久综合久中文字幕| 亚洲精品无码久久毛片| 无码激情做a爰片毛片AV片| 国产亚洲精品无码专区| 成在线人免费无码高潮喷水| 国产激情无码一区二区app| 日韩精品久久无码中文字幕| 日韩免费人妻AV无码专区蜜桃| 无码人妻精品一区二区三区久久 | 国产av无码专区亚洲av果冻传媒 | 亚洲av日韩av无码| 在线观看片免费人成视频无码| 成人无码AV一区二区| 亚洲av无码片在线播放| 无码精品A∨在线观看| 国产亚洲3p无码一区二区|